{"id":"https://genegraph.clinicalgenome.org/r/a512ee9e-bd74-4a24-9214-46e4bb2c1579v1.1","type":"EvidenceStrengthAssertion","dc:description":"TBCD was first reported in relation to early-onset neurodegenerative encephalopathy in 2016 (Miyake et al., PMID: 27666374). The clinical presentation includes intellectual disability with developmental regression, seizures, hypotonia, spasticity, and secondary microcephaly; brain imaging shows cerebral and cerebellar atrophy, thin corpus callosum, and secondary hypomyelination. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability, therefore, the following disease entities have been lumped into one disease entity: early onset progressive encephalopathy with brain atrophy and thin corpus callosum (PEBAT) (OMIM:617193), early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome (http://purl.obolibrary.org/obo/MONDO_0044646, ORPHA:496641). Twenty different variants (15 missense, 2 nonsense, 3 splice-disrupting) that have been reported in 15 probands in 6 publications (PMIDs: 27666374, 27666370, 28158450, 27807845, 29921875, 34423067) are included in this curation. More evidence is available in the literature (PMIDs: 27928163, 31240573, 31569255, 34943336, 36527993) but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease association is also supported by experimental evidence including functional assays demonstrating co-immunoprecipitation with TBCE, ARL2, and beta tubulin (PMID 27666374), expression evidence demonstrating decreased levels of TBCD in fibroblasts of affected individuals (PMID 27666370), functional assays demonstrating perturbations in cell proliferation and migration in mouse brain lysates with shRNA-mediated suppression of TBCD (PMID 28158450) and a morpholino-mediated TBCD knockdown in zebrafish that recapitulated some pathological features of the human disease (PMID 27807845).  In summary, TBCD is definitively associated with autosomal recessive TBCD-related early-onset neurodegenerative encephalopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Brain Malformations gene curation expert panel on 13Mar2025.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a512ee9e-bd74-4a24-9214-46e4bb2c1579","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2025-03-13T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2025-09-23T15:35:20.279Z","role":"Publisher"}],"curationReasonDescription":"replicated over time","curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9260b51d-65ed-43de-9e1a-2ceac980fc10_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9260b51d-65ed-43de-9e1a-2ceac980fc10","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","rdfs:label":"Miyake_Family 3_II-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.3365C>T (p.Pro1122Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8863580"}},{"id":"https://genegraph.clinicalgenome.org/r/18cf219d-37fb-4df0-b19b-3a0729700d77","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2280C>A (p.Tyr760Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8863014"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0005484","obo:HP_0001252","obo:HP_0001324","obo:HP_0010818","obo:HP_0001510","obo:HP_0000648"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4c2c5237-6b51-4603-b7b5-6b006aab8e39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/22f10f33-4145-4fc0-adec-26062b3e3f80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/18cf219d-37fb-4df0-b19b-3a0729700d77"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4c2c5237-6b51-4603-b7b5-6b006aab8e39","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c2c5237-6b51-4603-b7b5-6b006aab8e39_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4c2c5237-6b51-4603-b7b5-6b006aab8e39_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Coimmunoprecipitation assays using transient mammalian expression vectors showed partially lost binding capacity with ARL2, TBCE and endogenous tubulin compared with wild-type TBCD (Fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/22f10f33-4145-4fc0-adec-26062b3e3f80","type":"EvidenceLine","dc:description":"Scored as \"Other variant type\" given evidence for truncated protein.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22f10f33-4145-4fc0-adec-26062b3e3f80_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/22f10f33-4145-4fc0-adec-26062b3e3f80_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Coimmunoprecipitation assays using transient mammalian expression vectors showed partially lost binding capacity with ARL2, TBCE and endogenous tubulin compared with wild-type TBCD (Fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/635adcac-4956-4933-b31a-b64d7f753368_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/635adcac-4956-4933-b31a-b64d7f753368","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Flex_6215546","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c37c86a1-77c5-4a4b-abc1-c9612b609440","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.82781722_82781731del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA627839489"}},{"id":"https://genegraph.clinicalgenome.org/r/894e0224-1faf-4df7-9a5f-7b032e84a69d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1121C>T (p.Thr374Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA295243124"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0001250","obo:HP_0033725","obo:HP_0002120","obo:HP_0002342"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a16c3b10-c6e2-4c22-8b5a-c44b6824ed71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/894e0224-1faf-4df7-9a5f-7b032e84a69d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/77ebebf6-d3f0-4ec1-92c4-ac7ef65a5020_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/c37c86a1-77c5-4a4b-abc1-c9612b609440"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/a16c3b10-c6e2-4c22-8b5a-c44b6824ed71","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a16c3b10-c6e2-4c22-8b5a-c44b6824ed71_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a16c3b10-c6e2-4c22-8b5a-c44b6824ed71_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot (WB) analysis from patient fibroblasts show decreased level of TBCD protein (Fig 2A); transient transfection of mutant TBCD in HEK293T cells showed defective TBCD:b-tubulin:ARL2 complex formation (Fig 2B).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/77ebebf6-d3f0-4ec1-92c4-ac7ef65a5020","type":"EvidenceLine","dc:description":"Scored as predicted null given that it disrupts a canonical splice donor.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77ebebf6-d3f0-4ec1-92c4-ac7ef65a5020_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/2f44506e-77a9-484e-b6a2-9700d57bbbfd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f44506e-77a9-484e-b6a2-9700d57bbbfd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Flex_CMH444","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0d36de6b-3b87-431f-9e02-f2262d84679b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2981C>T (p.Thr994Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA295301594"}},{"id":"https://genegraph.clinicalgenome.org/r/11db3027-0f53-4047-b3bf-325118b370a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.3313G>A (p.Val1105Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3339040"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0034295","obo:HP_0000648","obo:HP_0001257","obo:HP_0001256"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/29107cb6-1e42-404f-8825-14fc8ce09af1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d36de6b-3b87-431f-9e02-f2262d84679b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/21c02bc6-9a40-4308-a1ed-2d41adc5bba5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/11db3027-0f53-4047-b3bf-325118b370a9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/21c02bc6-9a40-4308-a1ed-2d41adc5bba5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21c02bc6-9a40-4308-a1ed-2d41adc5bba5_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/29107cb6-1e42-404f-8825-14fc8ce09af1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29107cb6-1e42-404f-8825-14fc8ce09af1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/2c682af0-d382-42cc-a277-3947e8bf6fb9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c682af0-d382-42cc-a277-3947e8bf6fb9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","rdfs:label":"Pode_Shakkad_4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5237122-9f89-473c-b198-b7f2ab3e01c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.3192-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401635568"}},{"id":"https://genegraph.clinicalgenome.org/r/19e7329a-b882-4a85-af84-38e5c63826cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1757C>T (p.Ala586Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3723007"}}],"firstTestingMethod":"Exome sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d566f76b-53c1-4bd5-96c7-ee5ccf7def20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5237122-9f89-473c-b198-b7f2ab3e01c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/88027242-b249-4735-b9b3-608aa1ccbefa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","allele":{"id":"https://genegraph.clinicalgenome.org/r/19e7329a-b882-4a85-af84-38e5c63826cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/88027242-b249-4735-b9b3-608aa1ccbefa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88027242-b249-4735-b9b3-608aa1ccbefa_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/88027242-b249-4735-b9b3-608aa1ccbefa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID28158450 Fig3A","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d566f76b-53c1-4bd5-96c7-ee5ccf7def20","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d566f76b-53c1-4bd5-96c7-ee5ccf7def20_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/c829b6d4-507e-44ce-9414-aaac05003b3a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c829b6d4-507e-44ce-9414-aaac05003b3a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34423067","rdfs:label":"Quitman","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ab54ee96-4585-44da-ac7b-1779554cea47","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.230A>G (p.His77Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401622611"}},{"id":"https://genegraph.clinicalgenome.org/r/c2fc1455-0430-45b7-ab46-1079ae0d1398","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2048_2052dup (p.Glu685Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190545"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0005484","obo:HP_0011344","obo:HP_0001252","obo:HP_0033725"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e41ad50d-a04f-4613-a03e-9952149c3d71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34423067","allele":{"id":"https://genegraph.clinicalgenome.org/r/c2fc1455-0430-45b7-ab46-1079ae0d1398"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/4bc28155-a95c-4cfd-b291-8a3d5a8e206b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34423067","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab54ee96-4585-44da-ac7b-1779554cea47"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4bc28155-a95c-4cfd-b291-8a3d5a8e206b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bc28155-a95c-4cfd-b291-8a3d5a8e206b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e41ad50d-a04f-4613-a03e-9952149c3d71","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e41ad50d-a04f-4613-a03e-9952149c3d71_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/4b0f4174-649e-4602-a384-16dc1bdf0d85_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b0f4174-649e-4602-a384-16dc1bdf0d85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28158450","rdfs:label":"Edvardson_B11-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/19e7329a-b882-4a85-af84-38e5c63826cd"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0012444","obo:HP_0001332","obo:HP_0001250"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/58ea0dc8-45cd-4795-a847-6e8b1701311c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28158450","allele":{"id":"https://genegraph.clinicalgenome.org/r/19e7329a-b882-4a85-af84-38e5c63826cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/58ea0dc8-45cd-4795-a847-6e8b1701311c","type":"EvidenceLine","dc:description":"downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58ea0dc8-45cd-4795-a847-6e8b1701311c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/58ea0dc8-45cd-4795-a847-6e8b1701311c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blotting of cytosolic extracts reproducibly revealed a modest corresponding reduction (to about 40%) in A586V patient-derived cells compared to an age-matched wild type control (Fig. 3A).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f66e5cda-b470-4052-b9ca-60237d74a396_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f66e5cda-b470-4052-b9ca-60237d74a396","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Flex_F118_346","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001510","obo:HP_0001252","obo:HP_0033725","obo:HP_0005484","obo:HP_0001257","obo:HP_0000648","obo:HP_0001250","obo:HP_0002187","obo:HP_0002120"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/14833314-8f30-41fd-ada7-c3a2ca249a48_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/14833314-8f30-41fd-ada7-c3a2ca249a48","type":"EvidenceLine","dc:description":"downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14833314-8f30-41fd-ada7-c3a2ca249a48_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/14833314-8f30-41fd-ada7-c3a2ca249a48_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot (WB) analysis from patient fibroblasts show decreased level of TBCD protein (Fig 2);  transient transfected of mutant TBCD in HEK293T showed pronounced decay of protein level for the TBCD p.Pro1122Leu mutant (Figure S7), confirming the impact of mutation on protein stability.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3ff7b3d2-6bce-4c1a-ab2d-8703206dc859_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ff7b3d2-6bce-4c1a-ab2d-8703206dc859","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","rdfs:label":"Miyake_Family 2_II-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b26fda91-2ca8-4ea2-a02b-fad370eedd56","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2761G>A (p.Ala921Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602687"}},{"id":"https://genegraph.clinicalgenome.org/r/fe583214-51b6-4b3f-8d63-df0bca4d4775","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1160T>G (p.Met387Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602688"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002380","obo:HP_0001252","obo:HP_0001324","obo:HP_0002376","obo:HP_0002878","obo:HP_0005484","obo:HP_0011097","obo:HP_0000648","obo:HP_0001510","obo:HP_0001251"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5274b4ea-9519-4111-95a5-5db114878acc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe583214-51b6-4b3f-8d63-df0bca4d4775"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/20f31fa1-910b-4111-916b-ba9fc3505ec4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/b26fda91-2ca8-4ea2-a02b-fad370eedd56"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/20f31fa1-910b-4111-916b-ba9fc3505ec4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20f31fa1-910b-4111-916b-ba9fc3505ec4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/20f31fa1-910b-4111-916b-ba9fc3505ec4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"transient mammalian expression vectors showed partial loss of binding capacity with ARL2, TBCE and endogenous beta-tubulin compared with wild-type TBCD.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5274b4ea-9519-4111-95a5-5db114878acc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5274b4ea-9519-4111-95a5-5db114878acc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5274b4ea-9519-4111-95a5-5db114878acc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"transient mammalian expression vectors showed nearly complete loss of binding capacity with ARL2, and partial loss of binding with TBCE and endogenous beta-tubulin compared with wild-type TBCD.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/76eb165e-7b8f-4107-819d-8ea5fe1a9ae2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76eb165e-7b8f-4107-819d-8ea5fe1a9ae2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29921875","rdfs:label":"Gronberg_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c2e6795-efae-42e3-8a9e-26874e87560b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.3099C>G (p.Asn1033Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8863385"}},"firstTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7125ba62-fd48-4ae9-8eea-eb85147785a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29921875","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c2e6795-efae-42e3-8a9e-26874e87560b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7125ba62-fd48-4ae9-8eea-eb85147785a5","type":"EvidenceLine","dc:description":"downgraded due to homozygosity\n","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7125ba62-fd48-4ae9-8eea-eb85147785a5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7125ba62-fd48-4ae9-8eea-eb85147785a5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot (WB) analysis from patient fibroblasts show decreased level of TBCD protein \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c7ee71bf-3b2f-4bcb-a594-f67db47f7a08_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7ee71bf-3b2f-4bcb-a594-f67db47f7a08","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28158450","rdfs:label":"Edvardson_A11-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9924d77-3448-4446-877c-f595e6271645","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1423G>A (p.Ala475Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8862558"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0012444","obo:HP_0001263","obo:HP_0001332"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fd031899-4579-4084-a8ae-bc380901b936_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28158450","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9924d77-3448-4446-877c-f595e6271645"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/fd031899-4579-4084-a8ae-bc380901b936","type":"EvidenceLine","dc:description":"downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd031899-4579-4084-a8ae-bc380901b936_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/fd031899-4579-4084-a8ae-bc380901b936_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blotting of cytosolic extracts reproducibly revealed a dramatic reduction in the abundance of TBCD in A475T patient-derived cells to about 10% compared to an age-matched wild type control (Fig. 3A).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/11c75a83-2f2f-4b7e-944b-0f924f4dae39_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11c75a83-2f2f-4b7e-944b-0f924f4dae39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","rdfs:label":"Pode_Shakkad_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9924d77-3448-4446-877c-f595e6271645"},"firstTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aaddb771-7a14-471b-97b0-27232a68f46a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9924d77-3448-4446-877c-f595e6271645"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/aaddb771-7a14-471b-97b0-27232a68f46a","type":"EvidenceLine","dc:description":"downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aaddb771-7a14-471b-97b0-27232a68f46a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/aaddb771-7a14-471b-97b0-27232a68f46a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"functional data in PMID28158450","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0f0e8e71-e28f-4bf5-bc40-87358385366f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f0e8e71-e28f-4bf5-bc40-87358385366f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Flex_1455707","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd"},{"id":"https://genegraph.clinicalgenome.org/r/04620251-08e2-43d3-bf34-6ee99ad9b1d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.686T>G (p.Leu229Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8861712"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001257","obo:HP_0005484","obo:HP_0002187","obo:HP_0001252","obo:HP_0001510","obo:HP_0001250"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b85aeed1-a8d6-46b4-953c-5e4c09c9167d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7b25e5a-c6ad-4d5d-a1ba-441da78d7bfd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b7108859-b141-4c8d-a457-135094ffc425_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/04620251-08e2-43d3-bf34-6ee99ad9b1d6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b85aeed1-a8d6-46b4-953c-5e4c09c9167d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b85aeed1-a8d6-46b4-953c-5e4c09c9167d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b85aeed1-a8d6-46b4-953c-5e4c09c9167d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transient transfected of mutant TBCD in HEK293T showed pronounced decay of protein level for the TBCD p.Pro1122Leu mutant (Figure S7), confirming the impact of mutation on protein stability.)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b7108859-b141-4c8d-a457-135094ffc425","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7108859-b141-4c8d-a457-135094ffc425_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/b854c7ea-1551-41b3-971d-761d1ffee542_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b854c7ea-1551-41b3-971d-761d1ffee542","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","rdfs:label":"Miyake_Family 4_II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/69b78f5b-ebbb-4865-9249-79260927d8b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2810C>G (p.Pro937Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602689"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001324","obo:HP_0010818","obo:HP_0002376","obo:HP_0005484"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b5c89d0-a975-4ba8-88ec-4864db2f6fc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/69b78f5b-ebbb-4865-9249-79260927d8b3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9b5c89d0-a975-4ba8-88ec-4864db2f6fc7","type":"EvidenceLine","dc:description":"Downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b5c89d0-a975-4ba8-88ec-4864db2f6fc7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9b5c89d0-a975-4ba8-88ec-4864db2f6fc7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Coimmunoprecipitation assays using transient mammalian expression vectors showed partially lost binding capacity with ARL2, TBCE and endogenous tubulin compared with wild-type TBCD (Fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b0ffd17c-d694-4e17-a926-93bdfb3eff4a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0ffd17c-d694-4e17-a926-93bdfb3eff4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Flex_3641284","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ced86a03-4147-4b4c-947e-867038de9434","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1130G>A (p.Arg377Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8861900"}},{"id":"https://genegraph.clinicalgenome.org/r/306521a1-e4cf-474c-a176-5dbb617c721a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1876G>A (p.Ala626Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8862809"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002187","obo:HP_0033725","obo:HP_0002120","obo:HP_0005484","obo:HP_0001252","obo:HP_0000648","obo:HP_0001257","obo:HP_0001250"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3f6b84b1-587a-4054-903e-52940159f89c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/ced86a03-4147-4b4c-947e-867038de9434"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/12c3a42f-8014-4f0d-b90f-8e0ed8a8492c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","allele":{"id":"https://genegraph.clinicalgenome.org/r/306521a1-e4cf-474c-a176-5dbb617c721a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/12c3a42f-8014-4f0d-b90f-8e0ed8a8492c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12c3a42f-8014-4f0d-b90f-8e0ed8a8492c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/12c3a42f-8014-4f0d-b90f-8e0ed8a8492c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot (WB) analysis from patient fibroblasts show decreased level of TBCD protein (Fig 2A); transient transfection of mutant TBCD in HEK293T cells showed defective TBCD:b-tubulin:ARL2 complex formation (Fig 2B).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3f6b84b1-587a-4054-903e-52940159f89c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f6b84b1-587a-4054-903e-52940159f89c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3f6b84b1-587a-4054-903e-52940159f89c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot (WB) analysis from patient fibroblasts show decreased level of TBCD protein (Fig 2A); transient transfection of mutant TBCD in HEK293T cells showed defective TBCD:b-tubulin:ARL2 complex formation (Fig 2B).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/13d23ef3-79ce-49ba-88ce-3c2814b797f4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13d23ef3-79ce-49ba-88ce-3c2814b797f4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","rdfs:label":"Miyake_Family 1_II-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/df6033f2-6578-4646-a790-cf775ddf46d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.1564-12C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602685"}},{"id":"https://genegraph.clinicalgenome.org/r/825b486f-1f7a-4e76-8095-b5fc218f0c1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005993.5(TBCD):c.2314C>T (p.Arg772Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602686"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001510","obo:HP_0001324","obo:HP_0005484","obo:HP_0002878","obo:HP_0001252"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/074be224-e07b-4f81-9c9c-51e0ebcf90b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/825b486f-1f7a-4e76-8095-b5fc218f0c1b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/1c98ac57-8b4b-45f0-9027-00292ac80cc4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","allele":{"id":"https://genegraph.clinicalgenome.org/r/df6033f2-6578-4646-a790-cf775ddf46d9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/074be224-e07b-4f81-9c9c-51e0ebcf90b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/074be224-e07b-4f81-9c9c-51e0ebcf90b5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/074be224-e07b-4f81-9c9c-51e0ebcf90b5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Coimmunoprecipitation assays using transient mammalian expression vectors showed partially lost binding capacity with ARL2, TBCE and endogenous tubulin compared with wild-type TBCD (Fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1c98ac57-8b4b-45f0-9027-00292ac80cc4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c98ac57-8b4b-45f0-9027-00292ac80cc4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1c98ac57-8b4b-45f0-9027-00292ac80cc4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RNA studies demonstrate a 11-bp insertion of intronic sequence between exons 16\nand 17, confirmed at the cDNA level to cause a frameshift (p.Gly522Phefs*14) subjected to nonsense mediated mRNA decay (Fig S2).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d23ef97b-a69e-4d66-8533-aa8d2377da8e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f2afb87-7a15-4ec0-bb19-fd072ea31116","type":"Finding","dc:description":"Western Blot analysis of patient fibroblasts shows reduced TBCD expression compared to wildtype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666370","rdfs:label":"Western Blot analysis of patient fibroblasts","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/029ba9d8-004d-4a7b-8985-29c8ef72a910","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deb30c3d-7bc7-4cb2-89bd-ce5f27a5f4c4","type":"Finding","dc:description":"Wildtype TBCD co-immunoprecipitates with ARL2, TBCE, and beta tubulin","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666374","rdfs:label":"Co-immunoprecipitation with TBCE","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0d412a9-638b-4c5c-a948-86b5c85c17c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33fdaa67-45ea-4f88-8822-fb1160ab3e27","type":"FunctionalAlteration","dc:description":"fig 6","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28158450","rdfs:label":"shRNA knockdown in developing mouse brain"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8337935-2d37-4ce1-836a-f840be07301a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95345a4d-ccff-4e41-8b58-e5724dba4fa1","type":"Finding","dc:description":"same","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27807845","rdfs:label":"zebrafish morpholino","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":11787,"specifiedBy":"GeneValidityCriteria11","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/nXAm39j3ESc","type":"GeneValidityProposition","disease":"obo:MONDO_0044646","gene":"hgnc:11581","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d1ac5fbd-0d8e-4b6e-a8c4-d21f966a350f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}